Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
Grant Opportunity Analysis
The Centers for Disease Control and Prevention’s National Center for Emerging and Zoonotic Infectious Diseases, through the Rickettsial Zoonoses Branch, is funding a cooperative agreement to increase awareness and knowledge of alpha-gal syndrome in the United States. The program focuses on improving surveillance, patient care, and public understanding through networking and knowledge sharing among stakeholders, targeted education for the public and healthcare providers, and active or enhanced AGS surveillance. It is structured as a five-year effort and emphasizes CDC priorities such as gold-standard science, transparency, and evidence-based practices, while excluding unallowable costs such as research activities. Applications are due June 19, 2026, with electronic submissions required by 11:59 p.m. ET, and the opportunity offers awards ranging from $25,000 to $1,000,000 annually.
Eligible Applicants
Bona fide agents are eligible to apply. For more information about bona fide agents, please see the CDC webpage on Expediting the Federal Grant Process with an Administrative Partner located at https://www.cdc.gov/publichealthgateway/grantsfunding/expediting.html#Q2